These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 1236681

  • 1. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP, Marosi J, Fischer J, Takó J, Kiss N.
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [Abstract] [Full Text] [Related]

  • 2. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP, Marosi J, Szende L, Borbély L, Takó J, Fischer J.
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [Abstract] [Full Text] [Related]

  • 3. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
    Radó JP, Marosi J, Fischer J.
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
    [Abstract] [Full Text] [Related]

  • 4. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP, Marosi J, Borbély L, Takó J.
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the antidiuretic effect of 1-deamino-8d-arginine vasopressin (DDAVP) by glibenclamide in water-loaded healthy subjects.
    Radó JP, Borbély L.
    Endokrinologie; 1975 Sep; 66(1):88-93. PubMed ID: 817889
    [Abstract] [Full Text] [Related]

  • 6. Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidus.
    Radó JP, Marosi J.
    Endokrinologie; 1976 Jun; 67(2):220-9. PubMed ID: 954691
    [Abstract] [Full Text] [Related]

  • 7. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A, Tubiana-Rufi N, Harris A, Czernichow P.
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [Abstract] [Full Text] [Related]

  • 8. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L, Julesz J, László FA.
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [Abstract] [Full Text] [Related]

  • 9. Effects of DDAVP in cranial diabetes insipidus as compared to other antidiuretic drugs.
    Coculescu M, Antipa C, Cucu C.
    Endocrinologie; 1977 Jan; 15(4):275-81. PubMed ID: 563614
    [Abstract] [Full Text] [Related]

  • 10. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L, Mezei G, László FA.
    Acta Med Acad Sci Hung; 1975 Jan; 32(1):75-84. PubMed ID: 1233863
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin)].
    Limal JM, Mugner E, Czernichow P.
    Arch Fr Pediatr; 1977 Dec; 34(10):965-72. PubMed ID: 610662
    [Abstract] [Full Text] [Related]

  • 12. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
    Joo KW, Jeon US, Kim GH, Park J, Oh YK, Kim YS, Ahn C, Kim S, Kim SY, Lee JS, Han JS.
    Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
    [Abstract] [Full Text] [Related]

  • 13. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG.
    N Engl J Med; 1976 Mar 04; 294(10):507-11. PubMed ID: 1250255
    [Abstract] [Full Text] [Related]

  • 14. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA, Frölich JC.
    J Pharmacol Exp Ther; 1981 Apr 04; 217(1):87-91. PubMed ID: 7205662
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
    Radó JP, Marosi J, Fischer J.
    Pharmacology; 1977 Apr 04; 15(1):40-5. PubMed ID: 840889
    [Abstract] [Full Text] [Related]

  • 16. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F, Mezei G, Julesz J, Lázló FA.
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb 04; 19(2):63-8. PubMed ID: 7216552
    [Abstract] [Full Text] [Related]

  • 17. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
    Moses AM, Moses LK, Notman DD, Springer J.
    J Clin Endocrinol Metab; 1981 May 04; 52(5):910-3. PubMed ID: 7228994
    [Abstract] [Full Text] [Related]

  • 18. [The effect of vasopressin analogs on water metabolism].
    László F, Laczi F, Julesz J, Baláspiri L.
    Z Gesamte Inn Med; 1983 Nov 15; 38(22):248-50. PubMed ID: 6666181
    [Abstract] [Full Text] [Related]

  • 19. DDAVP in the treatment of diabetes insipidus: a clinical study.
    Graham JJ, Wise PH, Harding PE.
    Med J Aust; 1977 Jul 23; 2(4):113-6. PubMed ID: 895639
    [Abstract] [Full Text] [Related]

  • 20. Effect of iontophoretic patterns on in vivo antidiuretic response to desmopressin acetate administered transdermally.
    Nakakura M, Terajima M, Kato Y, Hayakawa E, Ito K, Kuroda T.
    J Drug Target; 1995 Jul 23; 2(6):487-92. PubMed ID: 7773610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.